Approval · Notice of Compliance 7776 · 2006
FENOFIBRATE: Notice of Compliance 7776
Issued February 20, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7776
- Date
- February 20, 2006
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- LIPIDIL SUPRA (Laboratoires Fournier S.A.S.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENOFIBRATE | 02249995 | Cancelled Pre Market |
| FENOFIBRATE | 02250004 | Cancelled Post Market |
Medicinal ingredients
- FENOFIBRATE 100 MG per CAP
- FENOFIBRATE 160 MG per CAP